An Unusual Case of Facial Hyperpigmentation Solved on Histopathology
- PMID: 27790561
- PMCID: PMC5072061
- DOI: 10.7860/JCDR/2016/20737.8504
An Unusual Case of Facial Hyperpigmentation Solved on Histopathology
Figures
![[Table/Fig-1]:](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f54/5072061/1250bca5bf2e/jcdr-10-WL01-g001.gif)
![[Table/Fig-2]:](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f54/5072061/1019b4f75912/jcdr-10-WL01-g002.gif)
![[Table/Fig-3]:](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f54/5072061/445e5cb5d2e3/jcdr-10-WL01-g003.gif)
Similar articles
-
[Plaque-type scleroderma associated with linear and oesophageal features and facial and extra-facial hemiatrophy].Ann Dermatol Venereol. 2007 Jan;134(1):68-71. doi: 10.1016/s0151-9638(07)88995-2. Ann Dermatol Venereol. 2007. PMID: 17384549 French.
-
[Micro-plasma radio frequency treatment for facial post-burn hyperpigmentation].Zhonghua Zheng Xing Wai Ke Za Zhi. 2014 Mar;30(2):99-101. Zhonghua Zheng Xing Wai Ke Za Zhi. 2014. PMID: 24941759 Chinese.
-
Brightening and Improvement of Facial Skin Quality in Healthy Female Subjects With Moderate Hyperpigmentation or Dark Spots and Moderate Facial Aging.J Drugs Dermatol. 2018 Dec 1;17(12):1310-1315. J Drugs Dermatol. 2018. PMID: 30586263 Clinical Trial.
-
Management of facial hyperpigmentation.Am J Clin Dermatol. 2000 Sep-Oct;1(5):261-8. doi: 10.2165/00128071-200001050-00001. Am J Clin Dermatol. 2000. PMID: 11702317 Review.
-
Reticulate hyperpigmentation in systemic sclerosis: a case report and review of the literature.J Med Case Rep. 2015 Sep 28;9:219. doi: 10.1186/s13256-015-0697-2. J Med Case Rep. 2015. PMID: 26412076 Free PMC article. Review.
Cited by
-
Clinical evaluation of a topical Unani pharmacopoeial formulation Tila-e-Kalf in the management of melasma (Kalf): A randomized controlled clinical trial.Avicenna J Phytomed. 2023 May-Jun;13(3):255-264. doi: 10.22038/AJP.2022.21346. Avicenna J Phytomed. 2023. PMID: 37654999 Free PMC article.
References
-
- Keller JM, Macaulay W, Nercessian OA, Jaffe IA. New developments in ochronosis: review of the literature. Rheumatol Int. 2005;25:81–85. - PubMed
-
- Maize JC, Maize JC, Metcalf J. Lever’s Histopathology of skin. 10th Edn. Lippincott Williams and Wilkins; 2009. Metabolic diseases of skin. In David E Elder, Elenitsas R, Murphy GF, Xu X; pp. 425–458.
-
- Merola JF, Meehan S, Walters RF, Brown L. Exogenous ochronosis. Dermatology Online Journal. 2008;14:6. - PubMed
-
- Ladizinski B, Mistry N, Kundu RV. Widespread use of toxic skin lightening compounds: medical and psychosocial aspects. Dermatol Clin. 2011;29:111–23. - PubMed
-
- Touart DM, Sau P. Cutaneous deposition diseases. Part II. J Am Acad Dermatol. 1998;39:527–44. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources